Rhea-AI Impact
Rhea-AI Sentiment
Rhea-AI Summary
SINTX Technologies, Inc. (NASDAQ: SINT) announced a Cooperative Research and Development Agreement (CRADA) with the U.S. Army Combat Capabilities Development Command Army Research Laboratory (DEVCOM ARL) to collaborate on ceramic additive manufacturing and ceramic matrix composites. This partnership is expected to leverage the strengths of both organizations in developing advanced technologies for hypersonic vehicle applications and other high-temperature materials.
  • None.
  • None.

The CRADA between SINTX Technologies and DEVCOM ARL signifies a strategic collaboration that could spur innovation and economic activity within the advanced ceramics sector. Advanced ceramic materials, particularly those used in high-temperature applications like hypersonic vehicles, are part of a niche but growing market. The agreement may lead to the development of new applications and improvements in ceramic additive manufacturing and CMCs, which could position SINTX favorably in the market. The potential increase in demand for these materials in defense applications could enhance SINTX's revenue streams and market share.

It is crucial to monitor the progression of this partnership, as successful outcomes could attract additional defense contracts and partnerships. The focus on high-temperature CMCs and ceramic 3D printing services could also open doors to non-military applications, such as in aerospace or automotive industries, expanding the company's customer base. Stakeholders should be aware of the long-term implications, including the potential for SINTX to become a key player in the advanced ceramics market, driving up investor interest and possibly the company's stock valuation.

The CRADA is a significant step for SINTX, as it aligns the company with the U.S. Army's research capabilities, potentially leading to advancements in defense-related technologies. Ceramic matrix composites and ceramic 3D printing have critical applications in defense, particularly for vehicles that require materials capable of withstanding extreme conditions, such as hypersonic flight. The collaboration could result in enhanced properties of ceramics, such as increased durability and heat resistance, which are essential for the performance and safety of military equipment.

From a defense technology perspective, the partnership's success could lead to a stronger defense industrial base and provide the U.S. military with a competitive edge in terms of technological capabilities. For investors, the implications are two-fold: there's the immediate positive sentiment around SINTX's association with a government entity and the longer-term potential for substantial contracts should the developed technologies be adopted by the military. This could lead to significant returns on investment, albeit with the understanding that defense contracts are subject to political and budgetary constraints.

The technical aspects of the CRADA focus on the development of ceramic additive manufacturing and CMCs. Ceramic additive manufacturing, or ceramic 3D printing, involves layer-by-layer construction of ceramic components, which allows for complex geometries and reduced material waste. CMCs are composed of ceramic fibers embedded in a ceramic matrix, offering superior strength and resistance to high temperatures compared to traditional materials. These materials are critical in applications where performance at extreme temperatures is necessary, such as in hypersonic vehicle structures.

The expertise of SINTX in these domains, combined with the research capabilities of DEVCOM ARL, could lead to significant advancements in material science. For businesses and investors, this partnership could mean the development of proprietary technologies and materials that may be patented, providing a competitive edge and potential licensing revenues. The long-term impact of these advancements could be substantial, not only for military applications but also for commercial sectors requiring high-performance materials.

SALT LAKE CITY, Jan. 30, 2024 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. ( (NASDAQ: SINT; “SINTX” or the “Company”), a manufacturer and developer of advanced ceramic materials and related technologies, announced that its wholly owned subsidiary Technology Assessment & Transfer, Inc. (TA&T) has entered into a Cooperative Research and Development Agreement (CRADA) with the U.S. Army Combat Capabilities Development Command Army Research Laboratory (DEVCOM ARL). This partnership is expected to leverage the strengths of both organizations in the areas of ceramic additive manufacturing (ceramic 3D printing) and ceramic matrix composites (CMCs).

According to its website, the U.S. Army DEVCOM Army Research Laboratory is the U.S. Army’s research laboratory strategically placed under the Army Futures Command. DEVCOM ARL is the Army’s sole foundational research laboratory focused on cutting-edge scientific discovery, technological innovation, and transitioning capabilities for the future Army (See: (

SINTX’s Millersville, MD facility, Technology Assessment and Transfer, Inc., began work on ceramic 3D printing in the mid 1990’s, printing its first component in 1998. SINTX now provides prototype and Low-Rate Initial Production (LRIP) ceramic 3D printing services, sells ceramic-filled resins that customers use in their own printing processes, and works with multiple customers in the development of printing solutions for new materials.

In parallel to ceramic 3D printing, SINTX’s Maryland site has also been developing ultra-high temperature CMCs, and building extensive capabilities in the densification of fiber-based preforms using both chemical vapor infiltration and polymer infiltration and pyrolysis. SINTX is excited to participate in the dramatic increase in the market need for these materials in hypersonic vehicle applications as one example.

Ann Kutsch, General Manager of the Maryland site, commented: “We have a highly skilled team of engineers and technicians here in Maryland, all of whom are instrumental in pushing this cutting-edge work forward. I look forward to optimizing our offerings in these markets while also working with DEVCOM ARL to build both teams’ knowledge and capabilities in advanced technologies.”


About SINTX Technologies, Inc.

SINTX Technologies is an advanced ceramics company that develops and commercializes materials, components, and technologies for medical and technical applications. SINTX is a global leader in the research, development, and manufacturing of silicon nitride, and its products have been implanted in humans since 2008. Over the past several years, SINTX has utilized strategic acquisitions and alliances to enter into new markets. The Company has manufacturing and R&D facilities in Utah and Maryland.

For more information on SINTX Technologies or its materials platform, visit

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 (PSLRA), including, but not limited to, statements regarding SINTX’s ability to effectively develop a range of innovative applications of our ceramic additive manufacturing capabilities, SINTX’s ability to commercialize its technologies and broaden the applications that benefit from such technologies, and other statements that are not based on historical fact. Such forward-looking statements are subject to a number of risks and uncertainties that may cause actual results to differ from current expectations. Risks and uncertainties that may cause such differences include, among other things: SINTX’s products may not prove to be as effective as other products currently being commercialized or to be commercialized in the future by competitors; risks inherent in manufacturing and scaling up to commercial quantities while maintaining quality controls and qualification standards; the uncertainties inherent in new product development, including the cost and time required to commercialize such product(s); market acceptance of SINTX’s products once commercialized; risks related to manufacturing products and market acceptance volatility in the price of SINTX’s common stock; SINTX’s ability to raise funding and other competitive developments. Readers are cautioned not to place undue reliance on the forward-looking statements, which speak only as of the date on which they are made and reflect management’s current estimates, projections, expectations and beliefs. There can be no assurance that any of the anticipated results will occur on a timely basis or at all due to certain risks and uncertainties, a discussion of which can be found in SINTX’s Risk Factors disclosure in its Annual Report on Form 10-K, filed with the Securities and Exchange Commission (SEC) on March 29, 2023, and in SINTX’s other filings with the SEC. SINTX disclaims any obligation to update any forward-looking statements. SINTX undertakes no obligation to publicly revise or update the forward-looking statements to reflect events or circumstances that arise after the date of this report.

Business and Media Inquiries for SINTX:
SINTX Technologies


What is the recent announcement by SINTX Technologies, Inc.?

SINTX Technologies, Inc. announced a Cooperative Research and Development Agreement (CRADA) with the U.S. Army Combat Capabilities Development Command Army Research Laboratory (DEVCOM ARL) to collaborate on ceramic additive manufacturing and ceramic matrix composites.

What is the ticker symbol for SINTX Technologies, Inc.?

The ticker symbol for SINTX Technologies, Inc. is SINT.

What are the areas of collaboration between SINTX Technologies, Inc. and DEVCOM ARL?

The collaboration focuses on ceramic additive manufacturing (ceramic 3D printing) and ceramic matrix composites (CMCs) for hypersonic vehicle applications and other high-temperature materials.

What is the focus of SINTX Technologies, Inc.'s Maryland site?

SINTX's Maryland site is focused on developing ultra-high temperature CMCs and extensive capabilities in the densification of fiber-based preforms using chemical vapor infiltration and polymer infiltration and pyrolysis.

Sintx Technologies, Inc.


SINT Rankings

SINT Latest News

SINT Stock Data

Surgical and Medical Instrument Manufacturing
United States of America

About SINT

amedica is the only manufacturer of medical grade silicon nitride, an innovative biomaterial technology ideal for use in spinal fusion and across a variety of medical applications. our silicon nitride features a unique nanosurface texture that promotes bone growth and addresses clinical needs by providing excellent imaging capabilities and demonstrating antibacterial characteristics. our interbody fusion devices and pedicle screw systems are designed to benefit both the patient and the surgeon. with the only fda registered and iso 1345 certified silicon nitride medical device manufacturing facility in the world and a strong sales and distribution organization, we are committed to providing innovative healthcare solutions that improve patient quality of life.